Indication
Lung Small Cell Carcinoma AJCC v7
2 clinical trials
4 products
Clinical trial
A Phase 2 Study of Cediranib in Combination With Olaparib in Advanced Solid TumorsStatus: Active (not recruiting), Estimated PCD: 2022-06-22
Product
CediranibProduct
OlaparibClinical trial
Phase 1/2 Study of Navitoclax Plus Vistusertib in Patients With Relapsed Small Cell Lung Cancer (SCLC) and Other Solid TumorsStatus: Terminated, Estimated PCD: 2021-07-28
Product
NavitoclaxProduct
Vistusertib